CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day CRBP SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
MISS
9.7%
8/5/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
-3.1%
5/6/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
MISS
-16.2%
3/11/2025
08:00 am
crbp
corbus pharmaceuticals holdings, inc.
BEAT
-2.1%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/16 Form 10-K Corbus Pharmaceuticals For: Dec 31 23.8%
3/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is now covered by analysts at Nomura. They set a "buy" rating and a $112.00 price target on the stock. 12.7%
3/12 Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.8%
3/18 Form 4 Corbus Pharmaceuticals For: Mar 17 Filed by: Millian Craig Stuart 10.0%
3/9 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Moran Sean F. 9.6%
3/18 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.3%
4/9 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.7%
5/10 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock. 5.2%
3/28 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.0%
1/14 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
Top News Decliners
12/9 Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System -9.1%
5/9 Q1/2019 3/31/2019 EPS -0.430 ZacksConsensus 0.020 ActVsEst (0.450) - Miss -8.9%
8/8 Form 8-K Corbus Pharmaceuticals For: Aug 08 -8.7%
2/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.75 price target on the stock. -8.5%
11/7 Q3/2019 9/30/2019 EPS -0.320 ZacksConsensus -0.360 ActVsEst 0.040 - Beat -8.0%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus -0.340 ActVsEst (0.070) - Miss -7.3%
3/10 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Salzmann Peter -6.8%
2/6 Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock -6.4%
8/13 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. -6.2%
3/5 Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 -6.1%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
CRBP
SPY
QQQ
SPX
CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
CRBP SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
12/27
09:12 am
crbp
Low
While hedge funds own 24% of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), retail investors are its largest shareholders with 46% ownership [Yahoo! Finance]
12/11
04:48 pm
crbp
Medium
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data Transcript [Seeking Alpha]
11/13
12:56 pm
crbp
Low
Corbus Pharmaceuticals (NASDAQ:CRBP) had its price target lowered by analysts at Royal Bank Of Canada from $55.00 to $53.00. They now have an "outperform" rating on the stock.
11/12
08:00 am
crbp
Medium
Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
11/6
08:00 am
crbp
Medium
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
10/31
05:31 pm
crbp
Low
Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window [Seeking Alpha]
10/31
02:40 am
crbp
High
Corbus Pharmaceuticals Announces Pricing of Public Offering
10/30
04:31 pm
crbp
High
Corbus Pharmaceuticals Announces Proposed Public Offering
10/29
10:07 am
crbp
Low
Corbus Pharmaceuticals (NASDAQ:CRBP) was given a new $39.00 price target on by analysts at Mizuho.
11/12/2025
08:00 am
crbp
9.7%
MISS
8/5/2025
08:00 am
crbp
-3.1%
BEAT
5/6/2025
08:00 am
crbp
-16.2%
MISS
3/11/2025
08:00 am
crbp
-2.1%
BEAT
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
11/13
12:31 pm
Maintains
Outperform
Outperform
RBC Capital
Low
-1.2%
11/13
12:31 pm
Maintains
Outperform
Outperform
RBC Capital
Low
-1.2%
10/20
09:14 am
Maintains
Outperform
Outperform
Wedbush
High
-13.1%
10/20
09:14 am
Maintains
Outperform
Outperform
Wedbush
High
-13.1%
10/20
08:47 am
Reiterates
Reduce
Reduce
Benchmark Co.
High
-13.6%
10/20
08:47 am
Reiterates
Reduce
Reduce
Benchmark Co.
High
-13.6%
10/20
08:08 am
Reiterates
Buy
Buy
HC Wainwright
High
-16.0%
12/18
04:05 pm
crbp
Low
Form 8-K Corbus Pharmaceuticals For: Dec 12
12/15
04:19 pm
crbp
Medium
Form SCHEDULE 13G/A Corbus Pharmaceuticals Filed by: Cormorant Asset Management, LP
12/15
04:18 pm
crbp
Medium
Form 4 Corbus Pharmaceuticals For: Dec 11 Filed by: Cormorant Asset Management, LP
11/14
01:23 pm
crbp
Low
Form SCHEDULE 13G/A Corbus Pharmaceuticals Filed by: Cormorant Asset Management, LP
11/12
04:31 pm
crbp
Medium
Form 10-Q Corbus Pharmaceuticals For: Sep 30
11/12
04:25 pm
crbp
Medium
Form SCHEDULE 13G Corbus Pharmaceuticals Filed by: CITADEL ADVISORS LLC
11/12
08:15 am
crbp
Medium
Form 8-K Corbus Pharmaceuticals For: Nov 12
11/3
08:02 am
crbp
Low
Form 8-K Corbus Pharmaceuticals For: Oct 30
11/3
08:00 am
crbp
Low
Form 424B5 Corbus Pharmaceuticals
Show more
Top News Gainers
3/16 Form 10-K Corbus Pharmaceuticals For: Dec 31 23.8%
3/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is now covered by analysts at Nomura. They set a "buy" rating and a $112.00 price target on the stock. 12.7%
3/12 Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.8%
3/18 Form 4 Corbus Pharmaceuticals For: Mar 17 Filed by: Millian Craig Stuart 10.0%
3/9 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Moran Sean F. 9.6%
3/18 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.3%
4/9 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.7%
5/10 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock. 5.2%
3/28 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.0%
1/14 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
Top News Decliners
12/9 Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System -9.1%
5/9 Q1/2019 3/31/2019 EPS -0.430 ZacksConsensus 0.020 ActVsEst (0.450) - Miss -8.9%
8/8 Form 8-K Corbus Pharmaceuticals For: Aug 08 -8.7%
2/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.75 price target on the stock. -8.5%
11/7 Q3/2019 9/30/2019 EPS -0.320 ZacksConsensus -0.360 ActVsEst 0.040 - Beat -8.0%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus -0.340 ActVsEst (0.070) - Miss -7.3%
3/10 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Salzmann Peter -6.8%
2/6 Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock -6.4%
8/13 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. -6.2%
3/5 Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 -6.1%